Viewing nowHanlim Lozartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 200712759 · Notified 2007.11.23
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension and is particularly effective in slowing the progression of kidney disease in patients with type 2 diabetes. It helps manage both blood pressure and protects kidney function, thereby improving the overall health management of patients.
This medicine may be taken with or without food, but it is recommended to take it at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally 2 times daily, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with other antihypertensive agents (e.g., low-dose diuretics). An additive effect was observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Children and adolescents aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication may cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by pregnant women or those who may become pregnant. Patients who have allergic reactions to this medication, severe liver dysfunction, certain genetic lactose metabolism disorders, or severe kidney disease should not take it. Elderly patients, those with hyperkalemia or slightly impaired liver function, and those with heart valve disease or cardiovascular conditions should use this medication cautiously, and periodic monitoring is necessary to avoid excessively low blood pressure or worsening kidney function. While generally safe, side effects such as muscle cramps, dizziness, low back pain, and upper respiratory infections may occur, and rarely serious adverse reactions such as angioedema, hepatitis, renal failure, hypotension, and urticaria have been reported. Particular attention is required as abrupt drops in blood pressure may lead to fainting or loss of consciousness; if any unusual symptoms occur, consult a physician immediately. This medication may raise potassium levels; therefore, taking it with potassium supplements or potassium-containing medications can be risky, and must be discussed with a doctor. It can interact with other blood pressure medications, diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so inform your healthcare provider if you are taking any other medications. Pregnant or lactating women should preferably avoid this medication; if necessary, breastfeeding should be discontinued when taking this drug. Children, especially those under 6 years of age or those with severely impaired kidney function, should not take this medication. It is essential to regularly check blood pressure, kidney function, and electrolyte levels while taking this medication for any abnormalities. Be cautious when driving or operating machinery, as dizziness or drowsiness may occur. In case of overdose, hypotension and bradycardia may develop; seek medical attention immediately if symptoms occur, and treatment will be adjusted according to the symptoms. Store this medication out of reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain the storage temperature between 1°C and 30°C to prolong the medication's effectiveness.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.